Cabaletta Bio Q4 EPS $(0.40) Beats $(0.47) Estimate

Cabaletta Bio (NASDAQ: CABA) reported Q4 losses of $(0.40) per share, surpassing the analyst consensus estimate of $(0.47) by 13.98%. This represents a 38.46% improvement compared to losses of $(0.65) per share in the same quarter last year.